Truist Securities analyst Gregory Fraser downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Hold.
Wells Fargo Maintains Equal-Weight on Vroom, Lowers Price Target to $2
Wells Fargo analyst Zachary Fadem maintains Vroom (NASDAQ:VRM) with a Equal-Weight and lowers the price target from $6 to $2.